Daiichi Sankyo and UMN Pharma Enter into Research Agreement for Norovirus Vaccine

February 14, 2014 Daiichi Sankyo and UMN Pharma Inc. today announced the conclusion of a collaborative research agreement for norovirus vaccine. Norovirus is one of the leading causes of infectious gastroenteritis and the number of infected people reported is increasing both in Japan and globally. While norovirus vaccine has not been approved in any countries, approximately 200,000 deaths of children …